Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: Analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain

Journal of General Virology

Volumn 85, Issue 2, 2004, Pages 471-482

  Kumar, Priti ^a   Krishna, Venkatramana D ^a,b   Sulochana, Paramadevanapalli ^c   Nirmala, Gejjehalli ^c   Haridattatreya, Maganti ^c   Satchidanandam, Vijaya ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Bhat Biotech India (P) Ltd   (India)

^c Vijayanagar Institute of Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; EPITOPE; HYBRID PROTEIN; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ALLELE; ANAMNESIS; ANTIGEN SPECIFICITY; ARTICLE; ASIA; CELL CULTURE; CELL MEMBRANE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; FLAVIVIRUS; GENE SEQUENCE; GENETIC CODE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; INCIDENCE; INTRACELLULAR TRANSPORT; JAPANESE ENCEPHALITIS VIRUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; RNA VIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; VIRUS ENCEPHALITIS; VIRUS GENOME; VIRUS NEUTRALIZATION;

ALLELES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENE PRODUCTS, TAT; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; MALE; MEMBRANE GLYCOPROTEINS; RECOMBINANT PROTEINS; RNA HELICASES; SERINE ENDOPEPTIDASES; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

FLAVIVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; JAPANESE ENCEPHALITIS VIRUS; RNA VIRUSES;

EID: 1342310216     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19531-0     Document Type: Article

References (39)

1. Aihara, H., Takasaki, T., Matsutani, T., Suzuki, R. & Kurane, I. (1998). Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J Virol 72, 8032-8036.
2. Becker-Hapak, M., McAllister, S. S. & Dowdy, S. F. (2001). TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256.
3. Chen, H. W., Pan, C. H., Liau, M. Y., Jou, R., Tsai, C. J., Wu, H. J., Lin, Y. L. & Tao, M. H. (1999). Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73, 10137-10145.
4. Chisari, F. V. (1997). Cytotoxic T cells and viral hepatitis. J Clin Invest 99, 1472-1477.
5. Co, M. D., Terajima, M., Cruz, J., Ennis, F. A. & Rothman, A. L. (2002). Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151-163.
6. Desai, A., Ravi, V., Chandramuki, A. & Gourie-Devi, M. (1995). Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus. Microbiol Immunol 39, 269-273.
7. Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Wierenga, E. A., Santantonio, T., Jung, M. C., Eichenlaub, D. & Pape, G. R. (1995 . Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006-1007.
8. Hoke, C. H., Nisalak, A., Sangawhipa, N. & 8 other authors (1988). Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319, 608-614.
9. Katial, R. K., Sachanandani, D., Pinney, C. & Lieberman, M. M. (1998). Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 5, 78-81.
10. Kimura-Kuroda, J. & Yasui, K. (1988). Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 141, 3606-3610.
11. Konishi, E., Kurane, I., Mason, P. W., Innis, B. L. & Ennis, F. A. (1995). Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 53, 278-283.
12. Konishi, E., Kurane, I., Mason, P. W., Shope, R. E., Kanesa-Thasan, N., Smucny, J. J., Hoke, C. H. & Ennis, F. A. (1998). Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 16, 842-849.
13. Konishi, E., Yamaoka, M., Khin-Sane-Win, Kurane, I., Takada, K. & Mason, P. W. (1999). The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 73, 5527-5534.
14. Konishi, E., Yamaoka, M., Kurane, I. & Mason, P. W. (2000). Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology 268, 49-55.
15. Ku, C. C., King, C. C., Lin, C. Y., Hsu, H. C., Chen, L. Y., Yueh, Y. Y. & Chang, G. J. (1994). Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol 44, 122-131.
16. Kumar, P. & Satchidanandam, V. (2000). Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood. Clin Diagn Lab Immunol 7, 578-583.
17. + T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun 71, 1929-1937.
18. Kumar, P., Uchil, P. D., Sulochana, P., Nirmala, G., Chandrashekar, R., Haridattatreya, M. & Satchidanandam, V. (2003b). Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 148, 1569-1591.
19. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 65, 1823-1828.
20. - cytotoxic T lymphocyte clones. J Gen Virol 76, 2243-2249.
21. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30, 2479-2487.
22. Lin, Y. L., Chen, L. K., Liao, C. L., Yeh, C. T., Ma, S. H., Chen, J. L., Huang, Y. L., Chen, S. S. & Chiang, H. Y. (1998). DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72, 191-200.
23. + cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol 154, 1287-1295.
24. + cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98, 1684-1691.
25. Mathew, A., Kurane, I., Green, S. & 7 other authors (1998). Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 72, 3999-4004.
26. Mathur, A., Arora, K. L. & Chaturvedi, U. C. (1983). Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 64, 805-811.
27. McMichael, A. J. & Rowland-Jones, S. L. (2001). Cellular immune responses to HIV. Nature 410, 980-987.
28. Miura, K., Onodera, T., Nishida, A., Goto, N. & Fujisaki, Y. (1990). A single gene controls resistance to Japanese encephalitis virus in mice. Arch Virol 112, 261-270.
29. Mosmann, T. R. & Sad, S. (1996). The expanding role of T cells with Th1, Th2 and more. Immunol Today 17, 138-146.
30. + T cells. J Gen Virol 77, 705-714.
31. Pan, C. H., Chen, H. W., Huang, H. W. & Tao, M. H. (2001). Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J Virol 75, 11457-11463.
32. Poland, J. D., Calisher, C. H., Monath, T. P., Downs, W. G. & Murphy, K. (1981). Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59, 895-900.
33. Rao-Bhau, L. N., Singh, G., Gowal, D., Saxena, S. N., Kobayashi, M., Oya, A. & Yoshioka, I. (1988). Safety & efficacy of Japanese encephalitis vaccine produced in India. Indian J Med Res 88, 301-307.
34. Schwarze, S. R., Hruska, K. A. & Dowdy, S. F. (2000). Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 10, 290-295.
35. + T cell help in generating functional CD8 T cell memory. Science 300, 337-339.
36. Shibagaki, N. & Udey, M. C. (2002). Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 168, 2393-2401.
37. Ting, S. H., See, E., Tan, H. C., Lee, M. A. & Ooi, E. E. (2001). Development of a simplified assay for the detection of neutralizing antibodies to Japanese encephalitis virus. J Virol Methods 93, 43-47.
38. Tsai, T. F., Chang, G. J. & Yu, Y. X. (1999). Japanese encephalitis vaccines. In Vaccines, 3rd edn, pp. 672-710. Edited by S. A. Plotkins & W. A. Orenstein. Philadelphia: W. B. Saunders.
39. + T-cell clones. J Virol 70, 3108-3117.